Search Results
Phase II Clinical Trial: Effects of Herceptin on Survival in Breast Cancer Patients
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
Herceptin and Chemotherapy Treatment Combo Increases Survival Rates in Early Breast Cancer Patients
Phase II ADAPT Trial in Patients With HER2+ and HR+ Early Breast Cancer
Trastuzumab Emtansine in HER2+ Breast Cancer
Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo
Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen
Phase II Clinical Trials
HER2 Positive Breast Cancer: Everything You Must Know
Tucatinib Combination Improved Survival in HER2–Positive Breast Cancer
TUXEDO-1: trastuzumab deruxtecan for the treatment of HER2-positive breast cancer brain metastases
